Stabilization of glucose-6-phosphate dehydrogenase oligomers enhances catalytic activity and stability of clinical variants.
G6PD deficiency
enzymopathy
erythrocytes
oligomer stabilization
therapeutic strategy
Journal
The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
received:
06
10
2021
revised:
13
01
2022
accepted:
16
01
2022
pubmed:
23
1
2022
medline:
16
4
2022
entrez:
22
1
2022
Statut:
ppublish
Résumé
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a genetic trait that can cause hemolytic anemia. To date, over 150 nonsynonymous mutations have been identified in G6PD, with pathogenic mutations clustering near the dimer and/or tetramer interface and the allosteric NADP
Identifiants
pubmed: 35065072
pii: S0021-9258(22)00050-3
doi: 10.1016/j.jbc.2022.101610
pmc: PMC8861134
pii:
doi:
Substances chimiques
NADP
53-59-8
Glucosephosphate Dehydrogenase
EC 1.1.1.49
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
101610Subventions
Organisme : NICHD NIH HHS
ID : R01 HD084422
Pays : United States
Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.